Ozempic and other glucagon-like peptide-1 (GLP-1) agonists are a transformative new class of medicines for the treatment of ...

Lantus, Combiflam, Amaryl and Allegra feature ... A line extension of one of Sanofi Indias flagship brand Combiflam, the launch of this new product marks the companys foray into the OTC headache ...

Three years later, health and beauty brand L’Oreal acquired a majority ... diabetes treatment Lantus, colorectal cancer drug Eloxatin, and lung, prostate and breast cancer drug Taxorete.

The non-profit drugmaker plans to launch biosimilars of Sanofi’s Lantus (insulin glargine), Novo ... amid a commercial environment where even brand products were seeing ‘80% to 90% erosion ...

President Trump has ordered the Treasury Department to stop minting pennies to save money. It costs almost four cents to make ...

North Carolina is one of several states announcing select committees or other projects mimicking the mission, and often the ...

Taking control of your brand can mean the difference between an unfulfilling job and a rewarding career. But how can you persuade others to take the reinvented you seriously? The author presents a ...

28 days Prescribing information Insulin glargine (rDNA origin) vial or cartridge Lantus vial or cartridge (Sanofi-Aventis) 28 days Prescribing information 70% insulin aspart protamine suspension ...

In brand strategy, “brand personality” refers to a unique blend of human characteristics associated with a brand. These traits shape how people perceive and interact with the brand, whether seen as ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.